Drugs / IPOL
last change Dec 2006 re-read 2 minutes ago

IPOL

Vaccine

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00148941 Comparator Jan 2005 → Nov 2006 diphtheria, tetanus GlaxoSmithKline Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IPOL ClinicalTrials.gov intervention name — accepted as the source's own label NCT00148941
Modality Vaccine “IPOL vaccineNCT00148941